Categories AlphaGraphs, Earnings, Health Care
Gilead Sciences reports Q3 earnings. Here’s everything you need to know
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of 2023.
Revenues came in at $7.05 billion in the September quarter, compared to $7.04 billion in the corresponding period of 2022. For fiscal 2023, the company expects product revenues to be in the range of $26.7 billion to $26.9 billion.
Adjusted net income was $2.29 per share in the third quarter, vs. $1.90 per share in the prior-year period. The company reported an unadjusted profit of $2.18 billion or $1.75 per share for the quarter, compared to $1.79 billion or $1.43 per share in Q3 2022.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
USB Earnings: US Bancorp Q1 profit jumps on higher interest income
U.S. Bancorp (NYSE: USB) Wednesday reported a double-digit growth in first-quarter earnings, reflecting an increase in net interest income. Total net revenue increased 3.6% from last year to $7.0 billion
Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today. Total sales increased 4% year-over-year to $10.35 billion. Organic sales growth was 6.9%. Net earnings grew 8.2% to
UAL Earnings: Highlights of United Airlines’ Q1 2025 financial results
Aviation giant United Airlines Holdings, Inc. (NYSE: UAL) on Tuesday announced financial results for the first quarter of 2025. Net income, on an adjusted basis, was $0.91 per share in
